SCHEMBL20596342

SCHEMBL20596342

c1ccc(-c2nc(-c3ccccc3)nc(-c3c(-n4c5ccccc5c5ccccc54)c(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)c(-c4ccccc4)c(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)c3-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
KDM4E B2RXH2 2/20 0.45
ATM Q13315 2/20 0.45
PTGER4 P35408 4/20 0.41
KMT2A Q03164 6/20 0.39
NPY5R Q15761 4/20 0.37
MEN1 O00255 5/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 2/20 0.36
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
IL1R1 P14778 1/20 0.34
NTSR1 P30989 1/20 0.33
HTT P42858 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22457791 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20596613 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20595940 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20596648 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20596461 0.92 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL20596643 0.89 PTGER4 (0.39) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL22457797 0.88 L3MBTL1 (0.43) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL22143369 0.87 ATM (0.44) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL22143352 0.87 ATM (0.44) L3MBTL1KDM4EATMPTGER4KMT2A
SCHEMBL21416199 0.87 L3MBTL1 (0.50) L3MBTL1KDM4EATMPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018237385-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2018-12-27 WO claimed
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed
WO-2018237385-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2018-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CLTB, CYBA L3MBTL1 575/4885KDM4E 3779/4885ATM 1853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.